Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

[Programmed Medical Device (SaMD) and Orphan Drug Innovation Processes and Industrial Systems].

PMID: 41485960 · 2026

R, e, i, , G, o, t, o, ;, , S, h, i, n, t, a, r, o, , S, e, n, g, o, k, u, ;, , K, o, t, a, , K, o, d, a, m, a

RevistaYakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Ano2026
PMID41485960

Resumo

The innovation patterns and institutional environments of software as a medical device (SaMD) were empirically, comparatively, and institutionally analyzed as SaMD is attracting attention as innovative medical technology. Data were collected on SaMD products approved by the U.S. Food and Drug Administration (FDA) and medical providers (n=581 and 268, respectively). The relationships among SaMD use, the interaction of SaMD with existing medical devices, and company characteristics were structural

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑